SEC Form 4 · accession 0001562180-16-001930
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederic H Moll
Director
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 7:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2016 | M | 12,500 | $0.48 | A | 266,478 | D | |
| Common StockF1 | Mar 3, 2016 | S | 12,500 | $18.32 | D | 253,978 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.48 | Mar 3, 2016 | M | 12,500 | D | — | May 18, 2016 | Common Stock | 12,500 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.26 to $18.42, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2The shares subject to the option are immediately exercisable. 1/36th of the shares subject to the option vest monthly over 36 months beginning June 1, 2006.